Metalead
1 known investors
metaLead develops orally available molecular therapeutics designed to selectively capture and remove specific toxic metal ions from the body, targeting metal-related diseases such as Wilson disease (copper accumulation) and lead poisoning. Its preclinical drug candidates aim to improve selectivity and efficacy over existing standards of care in the biotech/pharmaceutical field.
BiotechDeep TechMedical Devices
Investors · 1
Frequently asked questions
- What does Metalead do?
- metaLead develops orally available molecular therapeutics designed to selectively capture and remove specific toxic metal ions from the body, targeting metal-related diseases such as Wilson disease (copper accumulation) and lead poisoning. Its preclinical drug candidates aim to improve selectivity and efficacy over existing standards of care in the biotech/pharmaceutical field.
- Who are Metalead's investors?
- Metalead's investors include Kickfund.